The 2026 WNBA Commissioner’s Cup continues on Saturday, with the Atlanta Dream hosting the Washington Mystics at the Gateway Center Arena. It’s the first matchup between the two teams from the Eastern ...

Atlanta enters the game with a 5-2 record and one of the WNBA’s best defenses, a formula that has helped the Dream emerge as an early contender in the East. Rhyne Howard and Allisha Gray continue to ...

Caitlin Clark and the Indiana Fever (4-4) face the Atlanta Dream on Thursday, June 4, looking to bounce back from back-to-back losses. The Iowa women's basketball star is coming off her toughest ...

The Indiana Fever host the Atlanta Dream on Thursday (7 p.m. ET, Prime Video) at Gainbridge Fieldhouse in Indianapolis for one of the best head-to-head matchups in the WNBA. Thursday's Dream-Fever ...

The Commissioner's Cup is the WNBA's in-season tournament that many view as a preview of the WNBA playoffs, with the best teams in the league typically starting to emerge at this point in the season.

OKLAHOMA CITY — Last summer, Victor Wembanyama went to Hakeem Olajuwon for a crash course in footwork. Maybe he picked up another tip or two. Maybe, through some sort of “Dream Shake” osmosis, ...

This Sunday afternoon, the WNBA returns to NBC for the first time since 2002 and debuts on Peacock, with an exciting doubleheader. The action starts at 1:30 PM ET when A’ja Wilson and the defending ...

If you’re stuck waiting for your Miis to confess their love for one another, here are some handy tips to take them from friends to soulmate status. Miis develop crushes easily, but advancing ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Soccer has never exactly been America’s pastime, but from ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. While Nintendo hasn’t made an official tool to export, share, or ...

Compass Therapeutics said its cancer treatment improved progression-free survival in a recent trial, but didn't meet its secondary endpoint in overall survival. Shares sank 61% to $1.96, at one point ...